Organigram Global Launches SHRED Shotz Cannabis Beverage, Expanding FAST™ Innovation Platform
OGI sits 72% above its 52-week low of $0.85.
Summary
Organigram Global Inc. announced the launch of SHRED Shotz, a new compact, fast-acting cannabis beverage leveraging its successful SHRED brand and proprietary FAST™ nanoemulsion technology.
Key Events · Product Development and Regulatory · OGI
-
New Product Launch
Organigram Global introduced SHRED Shotz, a new 65ml single-serve cannabis beverage containing 10mg THC.
-
Leverages SHRED Brand & FAST™ Technology
The new product extends the successful SHRED brand, which exceeded $200 million in retail sales in 2025, and utilizes the company's fast-acting FAST™ nanoemulsion technology for a 15-minute onset.
-
Market Expansion
SHRED Shotz is designed to broaden the cannabis beverage category and is expected to be available in Canadian retailers starting March 2026.
Analysis · OGI · Life Sciences
This launch represents a strategic expansion of Organigram's product portfolio within the growing cannabis beverage market. By leveraging the strong equity of its SHRED brand, which has surpassed $200 million in retail sales, and integrating its proprietary FAST™ nanoemulsion technology for rapid onset, the company aims to attract new consumers and occasions. This move reinforces Organigram's focus on differentiated innovation and could contribute to continued market share leadership in Canada.
How filings like this one have moved
In the 30 days to Sep 12, 2026, 29.5% of the 1882 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.18%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, OGI was trading at $1.47 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $198M. The 52-week trading range was $0.85 to $2.24. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.